Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Hanson

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|February 20, 2022
Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health serviceEamonn R Maher, Julian Adlard, Julian Barwell, et al.
Journal of Medical Genetics|November 21, 2022
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: <i>RAD51C</i>, <i>RAD51D</i>, <i>BRIP1</i> and <i>PALB2</i>Helen Hanson, Anjana Kulkarni, Lucy Loong, et al.
Nature Genetics|July 5, 2024
Saturation genome editing of BAP1 functionally classifies somatic and germline variantsAndrew J Waters, Timothy Brendler-Spaeth, Danielle Smith, et al.
Journal of Medical Genetics|March 15, 2020
Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary networkAlice Garrett, Alison Callaway, Miranda Durkie, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 14, 2023
'A good decision is the one that feels right for me': Codesign with patients to inform theoretical underpinning of a decision aid websiteKelly Kohut, Kate Morton, Karen Hurley, et al.
BJS Open|September 5, 2023
Risk-stratified faecal immunochemical testing (FIT) for urgent colonoscopy in Lynch syndrome during the COVID-19 pandemicAnne G Lincoln, Sally C Benton, Carolyn Piggott, et al.
Journal of Medical Genetics|November 1, 2022
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in <i>BRCA1</i> and <i>BRCA2</i>Sue Philpott, Maria Raikou, Ranjit Manchanda, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2026
Integrating enriched case data from national laboratory testing with population-based case-control analyses: a novel statistical likelihood-ratio methodology for PS4 applied to 325,345 breast cancer cases and 671,006 controlsSophie Allen, Charlie F Rowlands, Alice Garrett, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHDAlice Garrett, Chey Loveday, Laura King, et al.
Familial Cancer|January 17, 2017
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controlsSibel Saya, Emma Killick, Sarah Thomas, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|February 20, 2022
Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health serviceEamonn R Maher, Julian Adlard, Julian Barwell, et al.
Journal of Medical Genetics|November 21, 2022
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: <i>RAD51C</i>, <i>RAD51D</i>, <i>BRIP1</i> and <i>PALB2</i>Helen Hanson, Anjana Kulkarni, Lucy Loong, et al.
Nature Genetics|July 5, 2024
Saturation genome editing of BAP1 functionally classifies somatic and germline variantsAndrew J Waters, Timothy Brendler-Spaeth, Danielle Smith, et al.
Journal of Medical Genetics|March 15, 2020
Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary networkAlice Garrett, Alison Callaway, Miranda Durkie, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|September 14, 2023
'A good decision is the one that feels right for me': Codesign with patients to inform theoretical underpinning of a decision aid websiteKelly Kohut, Kate Morton, Karen Hurley, et al.
BJS Open|September 5, 2023
Risk-stratified faecal immunochemical testing (FIT) for urgent colonoscopy in Lynch syndrome during the COVID-19 pandemicAnne G Lincoln, Sally C Benton, Carolyn Piggott, et al.
Journal of Medical Genetics|November 1, 2022
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in <i>BRCA1</i> and <i>BRCA2</i>Sue Philpott, Maria Raikou, Ranjit Manchanda, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2026
Integrating enriched case data from national laboratory testing with population-based case-control analyses: a novel statistical likelihood-ratio methodology for PS4 applied to 325,345 breast cancer cases and 671,006 controlsSophie Allen, Charlie F Rowlands, Alice Garrett, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHDAlice Garrett, Chey Loveday, Laura King, et al.
Familial Cancer|January 17, 2017
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controlsSibel Saya, Emma Killick, Sarah Thomas, et al.
Pageof 9